On Wednesday, the company said it was buying Veri, a personalized metabolic health company that employs continuous glucose monitors to share insights., as it also acquired digital identification tech company Proxy in May 2023.
With this in mind, Oura users have expressed interest in using continuous glucose monitors. According to a survey, 13 percent of users had tried one and 53 percent were interested in using one. Additionally, while they have required a prescription in the U.S., continuous glucose monitors are becoming increasingly accessible. For example, Abbott and Dexcom have both recently introduced continuous glucose monitors that are available over-the-counter.
“Meals is a way for you to log meals as part of your experience,” Hale said. “You take a photograph of a meal. It’ll keep the photograph. It’ll do some analysis of what’s in the meal. It’ll obviously record the timing and start to look for correlations.” of Veri and optional implementation of a continuous glucose monitor, Oura is also expanding how it is acquiring data.
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
출처: Crypto_Potato - 🏆 568. / 51 더 많은 것을 읽으십시오 »
출처: SInow - 🏆 273. / 63 더 많은 것을 읽으십시오 »
출처: Investingcom - 🏆 450. / 53 더 많은 것을 읽으십시오 »
출처: Covers - 🏆 341. / 59 더 많은 것을 읽으십시오 »
출처: ForbesTech - 🏆 318. / 59 더 많은 것을 읽으십시오 »
출처: Crypto_Potato - 🏆 568. / 51 더 많은 것을 읽으십시오 »